Company intelligence / Profile preview

Huaxi Bio

Nei Mongol Zizhiqu (Inner Mongolia), China

Ownership: Private
Development stage: Other

Overview

Huaxi Bio is a leading Chinese synthetic biology and bioactive substances platform company with commercially successful raw materials (notably several recombinant and native collagens and hyaluronic acid) and a diversified portfolio of medical aesthetic and functional skincare products, supported by both internal R&D and extensive partnerships; clinical efficacy data mainly pertain to medical devices and cosmetic performance, with broad market adoption in China.[1][2][3]

Therapeutic areas: Dermatology
Modalities: Recombinant proteinSmall moleculeBiologicAntibody fragment
Industry: Therapeutic Medical Devices

Partnerships

L'Oréal

Beyond the preview

Go deeper on Huaxi Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Huaxi Bio.

Explore the full profile